Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Leclercq

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Ophthalmology|March 29, 2022
ReplyMathilde Leclercq, David Saadoun
Rheumatology (Oxford, England)|September 12, 2014
Arterial thoracic outlet syndromeMathilde Leclercq, Isabelle Marie
Journal of Clinical Medicine|June 2, 2021
Old and New Challenges in Uveitis Associated with Behçet's DiseaseJulie Gueudry, Mathilde Leclercq, David Saadoun, et al.
Ocular Immunology and Inflammation|April 22, 2025
Prognostic Factors of Treatment Failure with First-Line Corticosteroid-Sparing Agents in Patients with Birdshot Chorioretinopathy: A Retrospective StudyPaul Goupillou, Mathilde Leclercq, Marc Muraine, et al.
Ocular Immunology and Inflammation|May 18, 2021
Differential Diagnosis of Vitritis in Adult PatientsSarah Touhami, Mathilde Leclercq, Dinu Stanescu-Segall, et al.
Haematologica|December 12, 2024
Acquired thrombotic thrombocytopenic purpura of unidentified pathophysiology in patients with severe disease: completing the landscape of thrombotic thrombocytopenic purpuraBérangère S Joly, Mathilde Leclercq, Ygal Benhamou, et al.
Ocular Immunology and Inflammation|August 2, 2025
Correlation Between Optical Coherence Tomography (OCT) and Serum Indirect Immunofluorescence Findings in a Case of Cancer Associated Retinopathy (CAR) Masquerading as White Dot SyndromePaul Goupillou, Mathilde Leclercq, Linda Zourdani, et al.
Haematologica|September 26, 2024
Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanismDelphine Simon, Mathilde Leclercq, Bérangère Joly, et al.
Journal of Ophthalmic Inflammation and Infection|July 18, 2023
Efficacious switching from subcutaneous to intravenous tocilizumab in patients with non-infectious non-anterior uveitisMathilde Leclercq, Paul Goupillou, Hélène Gomez, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 16, 2022
Potential Benefit of Rituximab in Rhupus Patients From a Single-Center: A Series of 16 CasesPascal Rottenberg, Pauline Brevet, Mathilde Leclercq, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Ophthalmology|March 29, 2022
ReplyMathilde Leclercq, David Saadoun
Rheumatology (Oxford, England)|September 12, 2014
Arterial thoracic outlet syndromeMathilde Leclercq, Isabelle Marie
Journal of Clinical Medicine|June 2, 2021
Old and New Challenges in Uveitis Associated with Behçet's DiseaseJulie Gueudry, Mathilde Leclercq, David Saadoun, et al.
Ocular Immunology and Inflammation|April 22, 2025
Prognostic Factors of Treatment Failure with First-Line Corticosteroid-Sparing Agents in Patients with Birdshot Chorioretinopathy: A Retrospective StudyPaul Goupillou, Mathilde Leclercq, Marc Muraine, et al.
Ocular Immunology and Inflammation|May 18, 2021
Differential Diagnosis of Vitritis in Adult PatientsSarah Touhami, Mathilde Leclercq, Dinu Stanescu-Segall, et al.
Haematologica|December 12, 2024
Acquired thrombotic thrombocytopenic purpura of unidentified pathophysiology in patients with severe disease: completing the landscape of thrombotic thrombocytopenic purpuraBérangère S Joly, Mathilde Leclercq, Ygal Benhamou, et al.
Ocular Immunology and Inflammation|August 2, 2025
Correlation Between Optical Coherence Tomography (OCT) and Serum Indirect Immunofluorescence Findings in a Case of Cancer Associated Retinopathy (CAR) Masquerading as White Dot SyndromePaul Goupillou, Mathilde Leclercq, Linda Zourdani, et al.
Haematologica|September 26, 2024
Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanismDelphine Simon, Mathilde Leclercq, Bérangère Joly, et al.
Journal of Ophthalmic Inflammation and Infection|July 18, 2023
Efficacious switching from subcutaneous to intravenous tocilizumab in patients with non-infectious non-anterior uveitisMathilde Leclercq, Paul Goupillou, Hélène Gomez, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 16, 2022
Potential Benefit of Rituximab in Rhupus Patients From a Single-Center: A Series of 16 CasesPascal Rottenberg, Pauline Brevet, Mathilde Leclercq, et al.
Pageof 4